Indefinite Delivery Contract W81K0225DA022
- Not listed
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Health Agency (DHA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company, for the supply of reagents, automated diagnostic testing equipment, and related services. The single-award contract has a ceiling value of $321,055.77 and a period of performance through September 30, 2025. Diasorin Inc. is a subsidiary of the parent company Diasorin S.P.A., which has an extensive track record as a federal contractor,...
- Diasorin Inc., a foreign-owned medical diagnostics subsidiary of Italian-based Diasorin S.P.A., was awarded a General Services Administration Multiple Award Schedule contract valued at $2.8 million on November 9, 2020, with an ultimate completion date of November 8, 2030. This civilian agency contract, administered through the Federal Acquisition Service, procures advanced chemiluminescence immunoassay analyzers and related diagnostic equipment, primarily the LIAISON XL and LIAISON XS analyzer...
- The subject contract is an Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit manufacturer of diagnostic testing equipment, assays, reagents, and related services. The contract has a total ceiling value of $291,245.30 and a period of performance through July 14, 2025. Under this IDC, Diasorin will provide the VA's VISN 17 network with its LIAISON XL analyzer reagents for a variety of infectious disease testing,...
- This indefinite delivery contract was awarded by the Defense Health Agency (DHA), a defense agency, to Diasorin Deutschland GMBH, a foreign-owned, for-profit manufacturer of medical products. The contract has a ceiling value of $732,571.15 and a period of performance through September 4, 2028. It is a single-award contract that does not utilize any set-asides. The contract is for the provision of medical testing supplies and laboratory equipment, specifically the RPP NXTAG (IVD-US) 96 test kits,...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite-delivery, indefinite-quantity contract to Diasorin Inc. to provide diagnostic testing services and related equipment. The contract has a potential value of $2,000,000 and period of performance from October 1, 2021 through September 30, 2026. Delivery orders issued against the contract include diagnostic testing for procalcitonin, vitamin D, tuberculosis, and COVID-19...
- The federal contract IDV award to Diasorin Inc., a foreign-owned for-profit medical diagnostics company, is a $10 million Federal Supply Schedule (FSS) contract from the Department of Veterans Affairs (VA). The contract, with a period of performance through March 2030, is for the provision of cost-per-test clinical laboratory analyzers and associated services. Diasorin Inc. is the prime contractor, with its parent company Diasorin S.P.A. providing overall corporate support. The contract provides...
- This federal contract IDV award was issued by the Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company, with Diasorin S.P.A. as the parent company. The single-award, firm-fixed-price indefinite-delivery/indefinite-quantity (IDIQ) contract, valued at $1,754,335.20, is for the lease of Liaison XL analyzers, installation, training, preventative maintenance, services/repairs, and associated reagents, consumables, and supplies for VA medical...
- DiaSorin Inc., a Minnesota-based subsidiary of Italian-based DiaSorin S.P.A., was awarded a single-award Blanket Purchase Agreement by the Department of Veterans Affairs Veterans Integrated Service Network 17 on December 15, 2025, with a ceiling value of $474,659.10 and an ultimate completion date of December 14, 2030. This contract, designated as the NTX Infectious Disease Blanket Purchase Agreement, procures advanced immunoassay analyzer systems, reagents, consumables, maintenance services,...
- Diasorin Molecular, LLC has been awarded a single-award Indefinite Delivery Contract with a ceiling value of $300,000 by Veterans Integrated Service Network 10 (VISN 10), a civilian division of the Department of Veterans Affairs, effective from December 1, 2025, through November 30, 2030. The contract procures the DiaSorin Liaison MDX Candida auris screening diagnostic solution, an automated real-time polymerase chain reaction (PCR) thermocycler system designed for rapid identification of...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded Diasorin Inc. a single award indefinite delivery contract to provide immunoassay testing supplies. The contract has a potential value of $1,397,135.10 and a period of performance through May 7, 2025. No set-aside provisions were applied. Delivery orders issued against this contract include $125,000 for supplies through May 24, 2024; $106,031.01 for supplies through May 7, 2025; $87,248...
Diasorin Inc. was awarded a single-award Indefinite Delivery Contract by the Defense Health Agency on October 1, 2025, with a ceiling value of $540,000 and a performance period extending through September 30, 2030. The contract procures LIAISON XL test kits, supplies, and analyzer equipment without the application of any set-aside designation, reflecting competitive procurement practices. As the U.S. Department of Defense's health services organization, the Defense Health Agency utilizes this indefinite delivery vehicle to establish pre-negotiated pricing and terms for the acquisition of diagnostic testing solutions to support military healthcare operations and readiness. The contract provides the Defense Health Agency with access to Diasorin Inc.'s advanced chemiluminescence immunoassay diagnostic platform, which serves critical infectious disease testing requirements across military healthcare networks. The LIAISON XL analyzer and associated consumables enable comprehensive laboratory diagnostics for conditions including COVID-19, tuberculosis, varicella, and cytomegalovirus, among other immunochemistry and infectious disease testing applications. As a subsidiary of Italian-based Diasorin S.P.A., Diasorin Inc. brings established expertise in providing specialized diagnostic equipment and reagents to federal healthcare agencies, including the Department of Veterans Affairs, Centers for Disease Control and Prevention, and other Defense Department entities. This indefinite delivery structure allows the Defense Health Agency to issue task orders against the established ceiling to meet evolving diagnostic testing demands while maintaining cost predictability through pre-established pricing mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/18/25 |